EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploring CAR-T Cell Therapy Side Effects: Mechanisms and Management Strategies

Yugu Zhang, Diyuan Qin, Arthur Churchill Shou, Yanbin Liu, Yongsheng Wang, Lingyun Zhou iD

Journal of Clinical Medicine · 22.09.2023 · 12 (19) · 6124

DOI: 10.3390/jcm12196124 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.09.2023. Verfasst von Yugu Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, 37 GuoXue Lane, Chengdu 610041, China. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technological Supports Project of Sichuan Province, Sichuan Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR) T cell therapy has revolutionized the treatment of malignancies, especially hematological tumors, but toxicities have tempered its success. The main impediments to the development of CAR-T cell therapies are the following: cytokine release syndrome (CRS), immune-effector-cell-associated neurotoxicity syndrome (ICANS), tumor lysis syndrome (TLS), and on-target/off-tumor toxicity (OTOT). This review summarizes these side effects’ underlying mechanisms and manifestations over time. It provides potential prevention and treatment according to the consensus grading, stressing the significance of establishing strategies that anticipate, reduce, and navigate the beginning of these side effects. It is essential to fully comprehend the mechanisms underlying these toxicities to create efficient treatment and preventive approaches.

Schlagwörter

Stichwörter der Autor:innen

CAR-T cellcytokine release syndromeimmune-effector-cell-associated neurotoxicity syndromemanagementmechanismsstrategies

Autor:innen und Institutionen

  • Division of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, 37 GuoXue Lane, Chengdu 610041, China.
  • Center of Infectious Diseases, West China Hospital of Sichuan University, 37 GuoXue Lane, Chengdu 610041, China.

ORCID-Profile: Lingyun Zhou

Förderung

  • National Natural Science Foundation of China
  • Science and Technological Supports Project of Sichuan Province
  • Sichuan Science and Technology Program
  • China Postdoctoral Science Foundation
  • Post-Doctor Research Project, West China Hospital
  • Post-Doctor Research Project, West China Hospital, Sichuan University

Zitieren

APA

Zhang, Y., Qin, D., Shou, A. C., Liu, Y., Wang, Y., & Zhou, L. (2023). Exploring CAR-T Cell Therapy Side Effects: Mechanisms and Management Strategies. Journal of Clinical Medicine, 12(19), 6124. https://doi.org/10.3390/jcm12196124

Vancouver

Zhang Y, Qin D, Shou AC, Liu Y, Wang Y, Zhou L. Exploring CAR-T Cell Therapy Side Effects: Mechanisms and Management Strategies. Journal of Clinical Medicine. 2023;12(19):6124. doi:10.3390/jcm12196124

BibTeX
@article{Zhang2023,
  author = {Zhang, Yugu and Qin, Diyuan and Shou, Arthur Churchill and Liu, Yanbin and Wang, Yongsheng and Zhou, Lingyun},
  title = {Exploring CAR-T Cell Therapy Side Effects: Mechanisms and Management Strategies},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {19},
  pages = {6124},
  doi = {10.3390/jcm12196124}
}
Kostenlos starten →